107 related articles for article (PubMed ID: 9149126)
1. Expression of E-cadherin and alpha- and beta-catenin mRNAs in ovarian cancers.
Fujimoto J; Ichigo S; Hirose R; Sakaguchi H; Tamaya T
Cancer Lett; 1997 May; 115(2):207-12. PubMed ID: 9149126
[TBL] [Abstract][Full Text] [Related]
2. Suppression of E-cadherin and alpha- and beta-catenin mRNA expression in the metastatic lesions of gynecological cancers.
Fujimoto J; Ichigo S; Hirose R; Sakaguchi H; Tamaya T
Eur J Gynaecol Oncol; 1997; 18(6):484-7. PubMed ID: 9443016
[TBL] [Abstract][Full Text] [Related]
3. Expression of E-cadherin and alpha- and beta-catenin mRNAs in uterine cervical cancers.
Fujimoto J; Ichigo S; Hirose R; Sakaguchi H; Tamaya T
Tumour Biol; 1997; 18(4):206-12. PubMed ID: 9218005
[TBL] [Abstract][Full Text] [Related]
4. Expressions of E-cadherin and alpha- and beta-catenin mRNAs in uterine endometrial cancers.
Fujimoto J; Ichigo S; Hori M; Tamaya T
Eur J Gynaecol Oncol; 1998; 19(1):78-81. PubMed ID: 9476066
[TBL] [Abstract][Full Text] [Related]
5. Expression of E-cadherin, alpha- and beta-catenin mRNAs in ovarian endometriosis.
Fujimoto J; Ichigo S; Hori M; Tamaya T
Eur J Obstet Gynecol Reprod Biol; 1996 Aug; 67(2):179-83. PubMed ID: 8841809
[TBL] [Abstract][Full Text] [Related]
6. Expression of E-cadherin, alpha-catenin and beta-catenin in normal ovarian surface epithelium and epithelial ovarian cancers.
Davies BR; Worsley SD; Ponder BA
Histopathology; 1998 Jan; 32(1):69-80. PubMed ID: 9522220
[TBL] [Abstract][Full Text] [Related]
7. Association of E-cadherin and beta-catenin immunoexpression with clinicopathologic features in primary ovarian carcinomas.
Faleiro-Rodrigues C; Macedo-Pinto I; Pereira D; Ferreira VM; Lopes CS
Hum Pathol; 2004 Jun; 35(6):663-9. PubMed ID: 15188131
[TBL] [Abstract][Full Text] [Related]
8. Immunohistochemical patterns for alpha- and beta-catenin, E- and N-cadherin expression in ovarian epithelial tumors.
Marques FR; Fonsechi-Carvasan GA; De Angelo Andrade LA; Böttcher-Luiz F
Gynecol Oncol; 2004 Jul; 94(1):16-24. PubMed ID: 15262114
[TBL] [Abstract][Full Text] [Related]
9. Clinical significance of E-cadherin-catenin complex expression in metastatic foci of colorectal carcinoma.
Ikeguchi M; Makino M; Kaibara N
J Surg Oncol; 2001 Jul; 77(3):201-7. PubMed ID: 11455558
[TBL] [Abstract][Full Text] [Related]
10. Alterations of E-cadherin, alpha-catenin and beta-catenin expression in neuroendocrine tumors of the gastrointestinal tract.
Li CC; Xu B; Hirokawa M; Qian Z; Yoshimoto K; Horiguchi H; Tashiro T; Sano T
Virchows Arch; 2002 Feb; 440(2):145-54. PubMed ID: 11964044
[TBL] [Abstract][Full Text] [Related]
11. Changes in the E-cadherin-catenin complex expression in early and advanced gastric cancers.
Joo YE; Rew JS; Kim HS; Choi SH; Park CS; Kim SJ
Digestion; 2001; 64(2):111-9. PubMed ID: 11684825
[TBL] [Abstract][Full Text] [Related]
12. [Detection of gene promoter methylation and mRNA, protein expression levels of E-cadherin in nasopharyngeal carcinoma].
Li Z; Lin SX; Liang YJ
Zhonghua Bing Li Xue Za Zhi; 2003 Feb; 32(1):25-30. PubMed ID: 12760799
[TBL] [Abstract][Full Text] [Related]
13. Expression of E-cadherin, alpha- and beta-catenins in patients with pancreatic adenocarcinoma.
Joo YE; Rew JS; Park CS; Kim SJ
Pancreatology; 2002; 2(2):129-37. PubMed ID: 12123093
[TBL] [Abstract][Full Text] [Related]
14. The reduced expression of e-cadherin, alpha-catenin and gamma-catenin but not beta-catenin in human lung cancer.
Toyoyama H; Nuruki K; Ogawa H; Yanagi M; Matsumoto H; Nishijima H; Shimotakahara T; Aikou T; Ozawa M
Oncol Rep; 1999; 6(1):81-5. PubMed ID: 9864406
[TBL] [Abstract][Full Text] [Related]
15. E-cadherin and alpha-, beta-, and gamma-catenin protein expression is up-regulated in ovarian carcinoma cells in serous effusions.
Davidson B; Berner A; Nesland JM; Risberg B; Berner HS; Tropè CG; Kristensen GB; Bryne M; Ann Florenes V
J Pathol; 2000 Dec; 192(4):460-9. PubMed ID: 11113863
[TBL] [Abstract][Full Text] [Related]
16. E-cadherin and alpha-, beta- and gamma-catenin expression in prostate cancers: correlation with tumour invasion.
Morita N; Uemura H; Tsumatani K; Cho M; Hirao Y; Okajima E; Konishi N; Hiasa Y
Br J Cancer; 1999 Apr; 79(11-12):1879-83. PubMed ID: 10206308
[TBL] [Abstract][Full Text] [Related]
17. An intact overexpressed E-cadherin/alpha,beta-catenin axis characterizes the lymphovascular emboli of inflammatory breast carcinoma.
Tomlinson JS; Alpaugh ML; Barsky SH
Cancer Res; 2001 Jul; 61(13):5231-41. PubMed ID: 11431364
[TBL] [Abstract][Full Text] [Related]
18. Expression patterns of alpha-, beta- and gamma-catenin in pancreatic cancer: correlation with E-cadherin expression, pathological features and prognosis.
Karayiannakis AJ; Syrigos KN; Polychronidis A; Simopoulos C
Anticancer Res; 2001; 21(6A):4127-34. PubMed ID: 11911306
[TBL] [Abstract][Full Text] [Related]
19. Altered gamma-catenin expression correlates with poor survival in patients with bladder cancer.
Syrigos KN; Harrington K; Waxman J; Krausz T; Pignatelli M
J Urol; 1998 Nov; 160(5):1889-93. PubMed ID: 9783980
[TBL] [Abstract][Full Text] [Related]
20. Progestins and danazol effect on cell-to-cell adhesion, and E-cadherin and alpha- and beta-catenin mRNA expressions.
Fujimoto J; Ichigo S; Hori M; Morishita S; Tamaya T
J Steroid Biochem Mol Biol; 1996 Mar; 57(5-6):275-82. PubMed ID: 8639463
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
